头孢洛林用于治疗耐甲氧西林严重感染：一项系统评价
Ceftaroline for Severe Methicillin-Resistant Infections: A Systematic Review.
作者信息
Cosimi Reese A, Beik Nahal, Kubiak David W, Johnson Jennifer A
机构信息
Department of Pharmacy, Massachusetts General Hospital.
Center for Drug Policy, Partners Healthcare.
出版信息
Open Forum Infect Dis. 2017 May 2;4(2):ofx084. doi: 10.1093/ofid/ofx084. eCollection 2017 Spring.
Abstract
Ceftaroline is approved by the Food and Drug Administration for acute bacterial skin and skin-structure infections and community-acquired bacterial pneumonia, including cases with concurrent bacteremia. Use for serious methicillin-resistant (MRSA) infections has risen for a multitude of reasons. The aim of this article is to review the literature evaluating clinical outcomes and safety of ceftaroline prescribed for serious MRSA infections. We conducted a literature search in Ovid (Medline) and PubMed for reputable case reports, clinical trials, and reviews focusing on the use of ceftaroline for treatment of MRSA infections. Twenty-two manuscripts published between 2010 and 2016 met inclusion criteria. Mean clinical cure was 74% across 379 patients treated with ceftaroline for severe MRSA infections. Toxicities were infrequent. Ceftaroline treatment resulted in clinical and microbiologic cure for severe MRSA infections. Close monitoring of hematological parameters is necessary with prolonged courses of ceftaroline.
摘要
头孢洛林已获美国食品药品监督管理局批准用于治疗急性细菌性皮肤及皮肤结构感染和社区获得性细菌性肺炎，包括并发菌血症的病例。由于多种原因，其用于治疗严重耐甲氧西林金黄色葡萄球菌（MRSA）感染的情况有所增加。本文旨在综述评估头孢洛林用于治疗严重MRSA感染的临床疗效和安全性的文献。我们在Ovid（医学文献数据库）和PubMed上进行了文献检索，查找关于头孢洛林用于治疗MRSA感染的知名病例报告、临床试验及综述。2010年至2016年间发表的22篇手稿符合纳入标准。在379例接受头孢洛林治疗严重MRSA感染的患者中，平均临床治愈率为74%。不良反应较少见。头孢洛林治疗可使严重MRSA感染实现临床和微生物学治愈。长期使用头孢洛林时，有必要密切监测血液学参数。
相似文献
1
Ceftaroline for Severe Methicillin-Resistant Infections: A Systematic Review.头孢洛林用于治疗耐甲氧西林严重感染：一项系统评价
Open Forum Infect Dis. 2017 May 2;4(2):ofx084. doi: 10.1093/ofid/ofx084. eCollection 2017 Spring.
2
A Mini-Review on Ceftaroline in Bacteremia Patients with Methicillin-Resistant (MRSA) Infections.头孢洛林用于耐甲氧西林金黄色葡萄球菌（MRSA）感染的菌血症患者的综述
Antibiotics (Basel). 2019 Mar 20;8(1):30. doi: 10.3390/antibiotics8010030.
3
The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients.头孢洛林酯治疗耐甲氧西林金黄色葡萄球菌心内膜炎和深部耐甲氧西林金黄色葡萄球菌感染：10 例患者的回顾性病例系列。
J Infect Chemother. 2013 Feb;19(1):42-9. doi: 10.1007/s10156-012-0449-9. Epub 2012 Jul 14.
4
Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus.头孢替唑肟：一种新型的广谱头孢菌素，对耐甲氧西林金黄色葡萄球菌具有活性。
Ann Pharmacother. 2011 Nov;45(11):1384-98. doi: 10.1345/aph.1Q225. Epub 2011 Oct 18.
5
Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.头孢洛林酯单药治疗耐甲氧西林金黄色葡萄球菌菌血症：一项比较临床结局研究。
Int J Infect Dis. 2017 Apr;57:27-31. doi: 10.1016/j.ijid.2017.01.019. Epub 2017 Jan 25.
6
Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy.耐甲氧西林金黄色葡萄球菌菌血症和心内膜炎采用头孢洛林挽救治疗。
J Antimicrob Chemother. 2012 May;67(5):1267-70. doi: 10.1093/jac/dks006. Epub 2012 Feb 6.
7
activity of ceftaroline: A novel antibiotic against methicillin-resistant .头孢洛林的活性：一种针对耐甲氧西林的新型抗生素。
Indian J Pathol Microbiol. 2016 Oct-Dec;59(4):496-498. doi: 10.4103/0377-4929.191798.
8
Ceftaroline as Salvage Monotherapy for Persistent MRSA Bacteremia.头孢洛林作为持续性耐甲氧西林金黄色葡萄球菌菌血症的挽救性单药治疗
Ann Pharmacother. 2016 Dec;50(12):1051-1059. doi: 10.1177/1060028016664361. Epub 2016 Aug 12.
9
Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.头孢洛林酯用于耐甲氧西林金黄色葡萄球菌血流感染的多中心观察性研究
Antimicrob Agents Chemother. 2017 Jan 24;61(2). doi: 10.1128/AAC.02015-16. Print 2017 Feb.
10
Combination Therapy With Vancomycin and Ceftaroline for Refractory Methicillin-resistant Staphylococcus aureus Bacteremia: A Case Series.万古霉素与头孢洛林联合治疗耐甲氧西林金黄色葡萄球菌难治性菌血症：病例系列
Clin Ther. 2017 Jan;39(1):212-218. doi: 10.1016/j.clinthera.2016.12.005. Epub 2016 Dec 27.
引用本文的文献
1
Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) among patients with oral infections in Sana'a City-Yemen.也门萨那市口腔感染患者中耐甲氧西林金黄色葡萄球菌（MRSA）的患病率。
BMC Oral Health. 2025 Jul 2;25(1):1047. doi: 10.1186/s12903-025-06247-0.
2
Efficacy and Safety of Vancomycin, Linezolid, and Ceftaroline in the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA): A Systematic Review and Meta-Analysis.万古霉素、利奈唑胺和头孢洛林治疗耐甲氧西林金黄色葡萄球菌（MRSA）的疗效和安全性：一项系统评价和荟萃分析。
Cureus. 2025 Jan 25;17(1):e77949. doi: 10.7759/cureus.77949. eCollection 2025 Jan.
3
Infective Endocarditis by Biofilm-Producing Methicillin-Resistant -Pathogenesis, Diagnosis, and Management.产生物膜的耐甲氧西林金黄色葡萄球菌所致感染性心内膜炎——发病机制、诊断与管理
Antibiotics (Basel). 2024 Nov 25;13(12):1132. doi: 10.3390/antibiotics13121132.
4
Relationship between the strength of biofilm production and the presence of and genes in isolated from skin and soft tissue infections.从皮肤和软组织感染中分离出的[具体菌种名称未给出]生物膜产生强度与[具体基因名称未给出]和[具体基因名称未给出]基因存在之间的关系。
Heliyon. 2024 Nov 19;10(23):e40524. doi: 10.1016/j.heliyon.2024.e40524. eCollection 2024 Dec 15.
5
Heartfelt Impact: A Descriptive Analysis of Ceftaroline-Containing Regimens in Endocarditis due to Methicillin-Resistant Staphylococcus aureus.深切影响：对含头孢洛林方案治疗耐甲氧西林金黄色葡萄球菌引起的心内膜炎的描述性分析
Infect Dis Ther. 2024 Dec;13(12):2649-2662. doi: 10.1007/s40121-024-01068-0. Epub 2024 Nov 2.
6
Short versus long duration of ceftaroline combination therapy and outcomes in persistent or high-grade MRSA bacteremia: A retrospective single-center study.短程与长程头孢洛林联合治疗持续性或中重度耐甲氧西林金黄色葡萄球菌菌血症的疗效和结局：一项回顾性单中心研究。
PLoS One. 2024 May 20;19(5):e0304103. doi: 10.1371/journal.pone.0304103. eCollection 2024.
7
The Home Environment Is a Reservoir for Methicillin-Resistant Coagulase-Negative Staphylococci and Mammaliicocci.家庭环境是耐甲氧西林凝固酶阴性葡萄球菌和哺乳动物葡萄球菌的储存库。
Antibiotics (Basel). 2024 Mar 19;13(3):279. doi: 10.3390/antibiotics13030279.
8
Antibiotic Resistance to Molecules Commonly Prescribed for the Treatment of Antibiotic-Resistant Gram-Positive Pathogens: What Is Relevant for the Clinician?对常用于治疗耐抗生素革兰氏阳性病原体的分子的抗生素耐药性：临床医生应关注什么？
Pathogens. 2024 Jan 19;13(1):88. doi: 10.3390/pathogens13010088.
9
Ceft-to-Ceft Study: Real-Life Experience with Ceftaroline and Ceftobiprole in Treatment of the Principal Infectious Syndromes in a Spanish Multicenter Hospital Cohort.头孢洛林与头孢比普的对比研究：西班牙多中心医院队列中头孢洛林和头孢比普治疗主要感染综合征的真实生活经验
Antibiotics (Basel). 2023 Dec 2;12(12):1692. doi: 10.3390/antibiotics12121692.
10
Contemporary Management of Staphylococcus aureus Bacteremia-Controversies in Clinical Practice.金黄色葡萄球菌菌血症的当代管理-临床实践中的争议。
Clin Infect Dis. 2023 Nov 30;77(11):e57-e68. doi: 10.1093/cid/ciad500.
本文引用的文献
1
Adverse Drug Reactions Associated with Ceftaroline Use: A 2-Center Retrospective Cohort.与使用头孢洛林相关的药物不良反应：一项双中心回顾性队列研究。
J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):740-6. doi: 10.1016/j.jaip.2016.03.008. Epub 2016 Apr 27.
2
High incidence of neutropenia in patients with prolonged ceftaroline exposure.长时间使用头孢洛林的患者中中性粒细胞减少症的发生率较高。
J Antimicrob Chemother. 2016 Jul;71(7):2010-3. doi: 10.1093/jac/dkw062. Epub 2016 Apr 13.
3
Tricuspid and mitral endocarditis due to methicillin-resistant Staphylococcus aureus exhibiting vancomycin-creep phenomenon.耐甲氧西林金黄色葡萄球菌引起的三尖瓣和二尖瓣心内膜炎表现出万古霉素耐药性增加现象。
BMJ Case Rep. 2015 Nov 3;2015:bcr2015211974. doi: 10.1136/bcr-2015-211974.
4
Neutropenia Associated with Long-Term Ceftaroline Use.长期使用头孢洛林相关的中性粒细胞减少症。
Antimicrob Agents Chemother. 2015 Oct 26;60(1):264-9. doi: 10.1128/AAC.01471-15. Print 2016 Jan.
5
Successful treatment of meticillin-resistant Staphylococcus aureus (MRSA) aortic prosthetic valve endocarditis with prolonged high-dose daptomycin plus ceftaroline therapy.采用延长疗程的高剂量达托霉素联合头孢洛林治疗耐甲氧西林金黄色葡萄球菌（MRSA）人工主动脉瓣心内膜炎取得成功。
Int J Antimicrob Agents. 2015 Aug;46(2):225-6. doi: 10.1016/j.ijantimicag.2015.04.006. Epub 2015 May 27.
6
Agranulocytosis with ceftaroline high-dose monotherapy or combination therapy with clindamycin.使用头孢洛林高剂量单药治疗或与克林霉素联合治疗导致的粒细胞缺乏症。
Pharmacotherapy. 2015 Jun;35(6):608-12. doi: 10.1002/phar.1596. Epub 2015 Jun 3.
7
Ceftaroline fosamil for the treatment of hospital-acquired pneumonia and ventilator-associated pneumonia.头孢洛林酯用于治疗医院获得性肺炎和呼吸机相关性肺炎。
Hosp Pract (1995). 2015;43(3):144-9. doi: 10.1080/21548331.2015.1037228. Epub 2015 May 8.
8
Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature.用头孢洛林和达托霉素治疗的达托霉素不敏感、万古霉素中介金黄色葡萄球菌心内膜炎：病例报告及文献简要综述
Infection. 2015 Dec;43(6):751-4. doi: 10.1007/s15010-015-0763-0. Epub 2015 Mar 25.
9
Ceftaroline in Combination With Trimethoprim-Sulfamethoxazole for Salvage Therapy of Methicillin-Resistant Staphylococcus aureus Bacteremia and Endocarditis.头孢洛林联合复方磺胺甲噁唑治疗耐甲氧西林金黄色葡萄球菌菌血症和心内膜炎的补救治疗。
Open Forum Infect Dis. 2014 Jul 8;1(2):ofu046. doi: 10.1093/ofid/ofu046. eCollection 2014 Sep.
10
Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USA.头孢洛林：在美国获批后针对耐甲氧西林金黄色葡萄球菌的临床及微生物学经验
Diagn Microbiol Infect Dis. 2015 Mar;81(3):183-8. doi: 10.1016/j.diagmicrobio.2014.11.016. Epub 2014 Dec 3.
Zotero 插件